#PROSCA22 opening in the beautiful Athens. 2 days of turning data into practice.

We may be small 🇧🇪 but we can take on our neighbors in 🇪🇺! Register now for EBU In-Service Assessment 2023! If you dare! 😏👇 examinations.ebu.com/examinations European School of Urology (EAU ESU) European Society of Residents in Urology Urologie Meetjesland OLV Aalst Urology Urologisch Centrum Noord West-Vlaanderen Société Belge d'Urologie BVU BMUC EBU #urology #exam

4/ #VIOLET: Terbium-161 PSMA-I&T. Can auger emitter therapy work? Will it target small volume disease better? ⏱Dose cohort 3 (7.4 GBq) being scheduled... James Buteau Louise Kostos Price Jackson Arun Azad Thanks @Isotopia_il PCF Science RIP JV bmj.com/content/371/bm…

Sean Collins Prostate SBRT @Tampa General Hospital Piet Ost yes, PSMA PET before sRT is included in the Primordium study. Please support this trial testing if 6mo Apa improves ppMFS clinicaltrials.gov/ct2/show/NCT04…

Nice poster ASCO #GU23 from Wee Loon Ong Amar Kishan and MARCAP consortium on testosterone recovery post ☢️#radiotherapy and 💉ADT in prostate cancer… can take quite some time!!! 3mo ADT = 6 mo to recover, 6mo ADT = 12mo to recover. OncoAlert #pcsm TROG Cancer Research

🔥🔥 primary endpoint analysis from Nicholas van As of PACE-A; SBRT versus robotic prostatectomy for #prostatecancer RCT. Co-primary toxicity endpoints (continence/bowel) #GU23 ASCO OncoAlert NHS. N=123, SBRT had ⬇️ pad use ⬇️ sexual dysfunction but ⬆️ bowel bother. All low grade.

#GU23 very practical data to help inform patients on probability of testosterone recovery, time to recovery, based on ADT duration and baseline levels #pcsm OncoAlert

Joe O’Sullivan presents CHHiP trial update 10-year data confirms 60/20 hypofractionated #radiotherapy as the standard of care for #prostatecancer (mostly intermediate). Good to see late significant GI/GU toxicity <1-2% at 10 years! @asco #GU23 #radonc #pcsm OncoAlert

🇧🇪 First day, the 10th edition of the BMUC meeting, with many friends ! Piet Ost Thanks for the invitation in #Bruxelles 🙏. Vedang Murthy Jb Beauval Thierry Roumeguere tombal

Beautiful opening #BMUC23 Outside: a rainbow 🌈 Inside: Urologist is the orchestra chief in #mCRPC among all other specialties 🎶 LumenNicolaas BMUC Société Belge d'Urologie BVU European Association of Urology (EAU)

Radiotherapy for Penile cancer is now supported by the European Association of Urology (EAU) guidelines! Vedang Murthy as the expert on stage! Amazing knowledge dissemination! Dose and field are important in adjuvant CRT. #BMUC23

Great to have attended the #BMUC23 conference! 🔬📊 The perspective 👀 from each specialty was truly insightful Kudos 👏 to the team for putting together an excellent event! #BMUC23 #urology #conference

#BMUC23 is a wrap. - 260 attendees: urologists, medical oncologists, researchers, industry all brought together. - 29 (inter)national faculty - Very practical information applicable to routine oncology care. 🔹SEE YOU IN 2024🔹

#BMUC23 year-in-review, all practice changing trials in 2h!

Excited to unveil the biological landscape of penile cancer at ASCO #GU24. Stop by poster board E7 for a journey into the penile cancer single-cell RNA sequencing wonderland 🧬🔬 Big shoutout to Maarten Albersen for all the guidance 🙏🏼

Nice talk from Piet Ost outlining approaches in recurrent/met #HSPC to optimise local control Clear evidence for metastasis directed therapy (MDT) ... less clear locally ... case for leaving prostate bed alone, esp given most tissue toxicity occurs there #BMUC2024 BMUC

Beautiful summary of key findings & impact of Stephen Freedland, MD's #EMBARKTrial from tombal BMUC #BMUC2024 And clear case for careful distinction of "Low risk" vs "High risk" #BCR Key factors (for HR): •GG4 or 5 •PSADT <1yr •Time to relapse <18m KU Leuven UZ Leuven